ProfileGDS4132 / 220427_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 78% 79% 83% 83% 78% 74% 80% 80% 77% 77% 71% 66% 69% 75% 68% 67% 70% 75% 73% 70% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101257.03378
GSM201543Muscle PCOS pioglitazone 121254.20379
GSM201544Muscle PCOS pioglitazone 161328.7583
GSM201545Muscle PCOS pioglitazone 201324.77983
GSM201829Muscle PCOS pioglitazone 231268.66778
GSM201830Muscle PCOS pioglitazon 251237.99874
GSM201831Muscle PCOS pioglitazone 271278.35280
GSM201832Muscle PCOS pioglitazone 31262.84180
GSM201833Muscle PCOS pioglitazone 41242.42177
GSM201834Muscle PCOS pioglitazone 81253.59177
GSM201835Muscle PCOS after pioglitazone 102209.54871
GSM201836Muscle PCOS after pioglitazone 122184.38566
GSM201837Muscle PCOS after pioglitazone 162187.96969
GSM201838Muscle PCOS after pioglitazone 202243.07175
GSM201839Muscle PCOS after pioglitazone 232199.56168
GSM201840Muscle PCOS after pioglitazone 252197.88167
GSM201841Muscle PCOS after pioglitazone 272195.90770
GSM201842Muscle PCOS after pioglitazone 32215.69375
GSM201843Muscle PCOS after pioglitazone 42225.04173
GSM201844Muscle PCOS after pioglitazone 82213.71770